Li Li

Clinical Efficacy and Tumor Microenvironment Influence in a Dose-Escalation Study of Anti-CD19 Chimeric Antigen Receptor T Cells in Refractory B-Cell Non-Hodgkin's Lymphoma

Weili Zhao, Wen Wu, Shu Cheng, 2019, Clinical Cancer Research.

B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma.

Michael L. Wang, K. Young, Z. Xu-Monette, 2018, Blood.

Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy

Depei Wu, Li Wang, Yao-hui Huang, 2023, Frontiers of Medicine.